Business Context and Reporting Period
This Form 8-K filing by Solar Capital Ltd. (not SLR Investment Corp.) covers events occurring between February 15, 2017, and February 22, 2017. The report details the formation of a new joint venture, the announcement of full-year 2016 financial results, and the closing of a follow-on debt offering.
Key Financial Metrics and Capital Structure
- Joint Venture Capitalization: Solar Life Science Program LLC (LSJV) has an expected total investable capital of approximately $700 million, including leverage.
- Equity Commitments: Aggregate equity capital commitment to LSJV is up to $350 million, split as follows: Solar Capital Ltd. ($50 million), Solar Senior Capital Ltd. ($75 million), Affiliates ($75 million), and Deerfield Management Company ($150 million).
- Debt Offering: The company closed a $100 million follow-on private offering of unsecured senior notes due 2022 with a 4.60% fixed interest rate.
- Total Debt Position: The aggregate amount of 2022 Unsecured Notes is now $150 million with a weighted average fixed interest rate of 4.53%.
- Leverage Target: LSJV is expected to be levered up to approximately 1.0x debt-to-equity once sufficient investments are made.
Material Changes and New Agreements
On February 22, 2017, the Company entered into a limited liability company agreement to form LSJV, a joint venture focused on investing in first lien loans to publicly-traded U.S. life science companies. Additionally, on February 15, 2017, the Company expanded its debt capacity by closing the aforementioned $100 million private placement of senior notes.
Guidance, Outlook, and Management Commentary
The filing references a press release (Exhibit 99.2) containing financial results for the year ended December 31, 2016; however, specific revenue, profit, or cash flow figures are not included in the text of this Form 8-K. Management indicates that LSJV is expected to invest the majority of its assets in the life science sector. The filing notes that the 2022 Unsecured Notes were issued to qualified institutional buyers pursuant to Rule 144A.
Investor Verification Checklist
- Verify the specific revenue, net income, and cash flow figures for the year ended December 31, 2016, by reviewing Exhibit 99.2 (Press Release) referenced in Item 2.02.
- Confirm the final closing conditions and leverage ratios for the Solar Life Science Program LLC (LSJV) by reviewing the LLC Agreement in Exhibit 10.1.
- Review the terms of the 2022 Unsecured Notes to confirm covenants and repayment schedules beyond the summary provided.
- Clarify the distinction between Solar Capital Ltd. and SLR Investment Corp., as the filing explicitly names Solar Capital Ltd. as the registrant.